1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Romania Pharmaceuticals and Healthcare Report Q1 2016

Romania Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 83 pages

Includes 3 FREE quarterly updates

BMI View: Consumer healthcare will be a key growth sector in the Romanian pharmaceutical market -supported by strong patient demand and the expansion of pharmacies in the country This comes as thesector is supported by positive pricing and advertising regulations in the country, thus allowing firms toleverage upon the expansion of pharmacies as well as the trend of self medication among younger patientsHousehold incomes are also expected to rise in line with Romania's economic outperformance in Europe,further buoying OTC drug sales, but also supporting wider pharmaceutical sector

Headline Expenditure Projections

- Pharmaceuticals: RON1419bn (USD428bn) in 2014 to RON1494bn (USD367bn) in 2015; +53% inlocal currency terms and -143% in US dollar terms Forecast unchanged from Q415

- Healthcare: RON3540bn (USD1068bn) in 2014 to RON3708bn (USD910bn) in 2015; +47% in localcurrency terms and -148% in US dollar terms Forecast unchanged from Q415

Table Of Contents

Romania Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Romania 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Romania 2011-2019) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Romania 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Romania 2011-2019) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Romania 2011-2019) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Romania 2011-2019) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Romania 2011-2019) 20
Generic Medicine Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Romania 2011-2019) 22
OTC Medicine Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Romania 2011-2019) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Romania 2013-2019) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Romania 2013-2019) 27
Pharmaceuticals and Healthcare Risk/Reward Index 28
Central And Eastern Europe Risk/Reward Index - Q1 2016 28
Romania Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 38
Intellectual Property Issues 38
PhRMA Special 301 Submission 39
Corruption 41
Pricing Regime 42
Reimbursement Regime 43
Market Overview 48
Healthcare System 49
Private Healthcare Provision 50
Healthcare Reform 51
Table: Healthcare Resources (Romania 2009-2014) 52
Table: Healthcare Personnel (Romania 2009-2014) 52
Table: Healthcare Activity (Romania 2009-2014) 53
Research And Development (RandD) 53
Clinical Trials 54
Epidemiology 55
Table: Romanian Cancer Incidence Rates, 2012-2035 56
Competitive Landscape 59
Pharmaceutical Sector 59
Generic Drugmakers 59
Research-Based Industry 60
Table: Members Of ARPIM, 2013 60
Pharmaceutical Company Developments 61
Table: Multinational Market Activity 61
Pharmaceutical Distribution 62
Pharmaceutical Retail 63
Company Profile 64
Antibiotice Iasi 64
LaborMed Pharma 67
Terapia Ranbaxy 69
Demographic Forecast 72
Table: Population Headline Indicators (Romania 1990-2025) 73
Table: Key Population Ratios (Romania 1990-2025) 73
Table: Urban/Rural Population and Life Expectancy (Romania 1990-2025) 74
Table: Population By Age Group (Romania 1990-2025) 74
Table: Population By Age Group % (Romania 1990-2025) 75
Glossary 77
Methodology 79
Pharmaceutical Expenditure Forecast Model 79
Healthcare Expenditure Forecast Model 79
Notes On Methodology 80
Risk/Reward Index Methodology 81
Index Overview 82
Table: Pharmaceutical Risk/Reward Index Indicators 82
Indicator Weightings 83

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.